The charity says that it had already been suffering a period of 'dire financial constraints' and the economic effects of coronavirus are now having a direct effect on funding.
The charity's Trustees and Executive Committee is still trying to find emergency funding to try and save the organisation, failing which it will close on the 31st March.
Equip EHV 1,4 is licensed for the active immunisation of horses to reduce clinical signs due to infection with Equine Herpesvirus 1 and 4 and to reduce abortion caused by EHV-1 infection.
Zoetis says it has already communicated directly with veterinary surgeons to inform them that Equip Rotavirus will be out of stock from the end of November 2017 until mid-2018.
During this time an imported vaccine for Rotavirus, will be available to provide an interim solution until supply is restored.
Practices wanting to buy the alternative imported Rotavirus vaccine will need to apply to the VMD for a Special Treatment Certificate (STC).
The company says it acknowledges the concern and frustration this causes its customers and wants to reassure the equine community that it is working diligently to restore the supply of Equip Rotavirus as soon as possible.
For more information, contact your Zoetis account manager or Zoetis technical team.
Zoetis has announced the introduction of Equimidine solution in a 50% larger plastic bottle.
The company says the new 15ml multi-dose presentation, now in plastic rather than glass, offers greater safety, as well as cost-saving advantages to practices.
Equimidine, containing 10mg/ml detomidine hydrochloride and methyl parahydroxybenzoate 1 mg/ml as a preservative, is a clear solution for intravenous injection. It has sedative and analgesic properties and is indicated for use either alone or in combination with butorphanol to facilitate the handling of horses for clinical examinations, minor surgical procedures and other manipulations. It can also be used with ketamine for short duration general anaesthesia for surgical procedures such as castration.
According to the company, the new 15ml plastic bottle is more cost-effective per dose than the old 10ml glass vial. It is also safer to use as the bottle is less likely to break if accidentally dropped. The multi-dose facility involves a tightly fitted rubber bung through which a sterile needle can be inserted to withdraw each dose.
Penny McCann, Equine Product Manager, Zoetis UK Ltd, said: "The new presentation provides practical benefits for vets and the larger bottle size means the product is now even more cost-effective."
For more information, speak to your Zoetis Account Manager, refer to the SPC or contact Zoetis Customer Support on 0845 3008034.
Kruuse has launched a range of seven specialized sterile surgical disposable drapes and gowns developed for the surgery team working in equine clinics or hospitals.
The company says its new surgical sets have been designed so they include a comprehensive set of sterile drapes, towels, instrument covers and adhesive tapes needed to perform particular procedures:
Andrew Groom, Managing Director, Kruuse UK Ltd. said: "This exciting new range of products increase the Kruuse's equine product portfolio and develop further our commitment to provide specialist species available products to support the veterinary practitioner."
Woodley Equipment Company has announced that Veterinary Parasep Faecal Filters are now available exclusively from the company.
According to the Woodley, the filters have been developed in conjunction with an independent leading veterinary Institution and offer an improved method of determining Worm Egg Counts (WEC) on cattle, sheep and horses. Flotation methods for WEC can require several Specific Gravity solutions to cover different parasites. The two common flotation methods, ‘Modified McMaster' and ‘Improved Modified McMaster', both use Saturated NaCL and are both catered for with Veterinary Parasep.
Woodley says the key advantages of the new filters are:
For a more information about The Veterinary Parasep please email sales@woodleyequipment.com or call the customer service team on +44 (0) 1204 669033 ~ Option 1.
Alternatively, visit http://www.woodleyequipment.com/.
The company says it is launching the new slCT after achieving success imaging horses in collaboration with its UK-based clinical trial sites.
The new standing CT scanner has a unique low, flat platform for quick and easy entry and exit of the standing sedated horse.
The system uses a dual-concentric ring design which enables the detector plate to remain very close to the region of interest, thereby improving image quality.
Hallmarq says slCT is a good fit for equine practices wanting to step up to 3D imaging in the evaluation of their lameness cases.
Bell Equine in Kent, Sussex Equine in Ashington, and Berkshire- based Donnington Grove Equine were involved in early trials of novel system.
Dr Elisabetta Giorio from Donnington Grove says slCT complements their sMRI which highlights soft tissue and metabolic changes: “The combination of MRI and CT was a useful tool to have and helped with surgical planning and decision making".
For more information, visit: https://hallmarq.net/
Dr Wendy Talbot BVSc DipECEIM MRCVS, Equine National Veterinary Manager at Zoetis said: “Fast equine faecal egg count results are crucial for the appropriate and timely treatment of gastrointestinal parasites, and to detect the increasingly concerning issue of dewormer resistance in horses.
"This technology is proven to be as accurate at identifying Strongyle spp. and Parascaris spp. as a board-certified parasitologist, delivering fast, reliable and shareable results within 10 minutes.1”
Zoetis says study results have demonstrated the AI capability within the Vetscan Imagyst to be up to 99% in agreement with board-certified parasitologist results1.
This, says the company, allows for rapid identification of high shedders versus low shedders to enable strategic targeted deworming protocols to be implemented.
Reference
BVA President Gudrun Ravetz said: "Veterinary View not only highlights some of the veterinary profession's fantastic work, but complements our joint project with RCVS, Vet Futures, in exploring how the profession can best shape its own future. We hope it will stimulate debate among vets, and the wider community in which we work, about both the big challenges and opportunities that the veterinary profession is facing."
The series includes a number of videos which showcase more recent industry developments:
Stem Cell therapy for the treatment of canine osteoarthritis (VetCell Therapeutics)
Pharmtrax, a mobile device for vets to record work and dispensing on the farm (Henry Schein Animal Health)
Hormone implants as an alternative to castration (Virbac Animal Health)
Practice management support from Zoetis
Preventing an epidemic of equine flu (Merial Animal Health)
The vaccine will be available to order directly from Merial on receipt of a Special Import Certificate (SIC) issued by the VMD to the named vet. The SIC is only required once but needs to accommodate all potential doses required, enabling Merial to supply to direct orders from the practice.
The product is available in 10 dose packs at a net price of £89.00 per pack.
For further information, contact Merial Customer Support Centre (UK) on 0870 6000 123 or your local equine territory manager.
The Land Rover Burghley Horse Trials has announced a £15,000 bursary to the Animal Health Trust. The bursary will be used to help fund the development of a rapid result blood test to identify horses infected with Strangles.
The AHT has already developed a test that can detect the disease, however the result is not known for 48 hours. The aim of the new research is to develop the test to produce a result within 10 minutes. The test, which is being developed in conjunction with Forsite Diagnostics Ltd, will be a useful tool for disease screening at sales and competitions.
"As an independent charity we receive no government funding and this bursary is extremely important to us and we are delighted to be working in partnership with The Land Rover Burghley Horse Trials on this specific project," said Dr Richard Newton of the AHT who is carrying out the research in partnership with Professor Andrew Waller. "Without this vital funding to carry out the painstaking work that will give us the confidence to launch the test, it will remain no more than a theoretical possibility."
The Bursary will be presented at this year's Land Rover Burghley Horse Trials (1- 4 September 2011) - in recognition of the 50th Anniversary of the event.
"With increasing horse movement, not only world-wide but closer to home between competitions and livery yards, preventing the spread of disease is an increasingly important challenge facing the horse world," said Elizabeth Inman Director of the Trials. "We are delighted to be able to play a part in this challenge and hope that this anniversary bursary will help to fast-track this new test out of the laboratory and into the field and thereby help reduce the spread of what is a horrible disease for horses and owners."
The webinar will take place at 11am and will be repeated at 7.30pm for those who are unable to listen during the day.
Hosted by Zoetis vet Dr Wendy Talbot the session will last for approximately an hour and equates to 8 AMTRA CPD points.
Wendy will explain the current situation and recommended approaches to help slow resistance.
The webinar will conclude with a live Q&A to give everyone the opportunity to discuss any queries, concerns or common questions they hear from their customers with Wendy.
Zoetis Equine Product Manager, Penny McCann said: "Our webinars continue to be very well received.
“This one is particularly important as it explains the important new thinking around the use of anthelmintics in order to address the serious challenge of resistance.
"It’s a must for all those involved with prescribing.”
To book the 11am webinar: https://register.gotowebinar.com/register/6163460189961597967 To book the 7.30pm webinar: https://register.gotowebinar.com/register/6394015684169009164
Equine obesity is a growing problem not just in the UK but around the world. The debate explored how various sectors of the equestrian industry see the challenges faced by people who are struggling to manage their horse’s weight. It included the views of equine vet Lucy Grieve, horse owner Helen Gale, livery yard owner and coach Beth Maloney, nutritionist Liz Bulbrook, competition judge David Ingle and equine welfare officer Penny Baker.
The session was chaired by equine vet and nutrition specialist Professor Pat Harris with the support of Dr Tamzin Furtado, a social scientist with a special interest in human behaviour change for animals.
The panellists shared their views on what they believed to be the blocks for horse owners in recognising obesity and addressing the problem.
They identified the importance of empowering owners and working with them to make step by step changes with the support of a reliable and trusted team including vet, nutritionist, yard owner and farrier.
Lucy said: “Vets are in unique and privileged position to provide an achievable and effective tailor-made strategy for individual horses.
"We must all learn to overcome avoidance and engage recognise, accept and understand, and tailor a solution.”
Helen added: “Owners need to be able to recognise and acknowledge that their horse has a weight problem and be motivated to take action. Communication is key. It’s important for others to understand why you are following the advice form vets and other experts and how they can best help."
There was recognition that a bespoke approach is needed for every horse, owner and situation. Some livery owners may face challenges in changing management practices and peer pressure on a yard may prevent people implementing intake restriction measures such as a grazing muzzle or restricted turnout.
Beth said: “Peer pressure can be daunting and there can be a lack of confidence that you are doing the right thing."
Communication and proactive signposting to reliable advice and scientific information were identified as pivotal, not only in helping to identify weight changes but also to build horse owners’ knowledge and confidence. This would build a clearer understanding of the calorific value of feeds and of grass and forage, what constitutes a balanced diet, the importance of regular exercise and weight monitoring, being able to identify the difference between fat and muscle and being familiar and comfortable with the range of weight control tactics, such as grazing muzzles, restricted grazing and track systems.
The language used was also identified as important; gauging the needs and response of the individual and asking the owner what they think, would be more effective than using potentially inflammatory language - for example choosing the phrase ‘fat pad’ rather than the terms ‘overweight’ or ‘obese’.
Lucy said: “If we are all being really honest with ourselves obesity is neglect. I doubt many vets would walk away from an emaciated horse or an infected wound or a cloudy eye so why are we so willing to walk away from these ticking time bombs which are actually a real welfare issue as the animal is potentially at risk of losing their life?”
You can buy tickets for a replay of the debate for £5, here: https://www.eventbrite.co.uk/e/the-great-weight-debate-equine-playback-tickets-138080533593
The 29th National Equine Forum will be held online on Thursday 4th March 2021. Tickets will be available in February 2021. If you'd like to be notified when they become available, you can subscribe here: https://www.nationalequineforum.com/subscribe/
Equistro® has produced a dust-free pelleted presentation of Secreta Pro, following requests from clients. Secreta Pro-Max® was launched to vets at BEVA Congress.
Secreta Pro is a respiratory supplement used to support the bronchial system and natural defences on a long term basis.
For more information on Secreta Pro-Max® and all Equistro products, please visit http://www.equistro.co.uk/, or contact your Vetoquinol representative.
Dechra Veterinary Products, manufacturer and distributor of Equipalazone®, has launched a new website with up-to-date advice and guidance on the subject of equine pain management for horse owners: http://www.equinepainmatters.com/
Dechra says the website offers owners a place to go for information about pain in their horse including causes, diagnosis and the tools and techniques that their vet may use to treat pain. Owners will also be able to download anatomy charts and information leaflets on topics such as pain management, lameness, anaesthesia, sedation, euthanasia, the importance of microchipping and wound management.
Larry King, equine product manager at Dechra said: "This website is great for horse owners as they now have one place to go for information about equine pain matters. It will help them gain a better understanding of managing pain in their horses and the critical role that their vet plays in this area. Veterinary practices can also refer owners to it to support their consultation. This is the first website to put all this information together, so we are sure it will be popular.
"Cards with the new website address are available for practices to hand out to clients. "The website allows clients to browse the site in the comfort of their own home and is also ideal for practices with limited storage space for client information materials."
Dechra also encourages practices that have their own websites to link directly to www.equinepainmatters.com. Practices can order hand-out cards by contacting Dechra on 01743 441632 or email marketing@dechra.com.
The Disciplinary Committee heard three charges against Dr Jones.
The first and second charges were that, in March 2018, Dr Jones made signed entries in the passports and made corresponding entries in clinical records of four horses indicating that he had administered an influenza vaccination booster to each horse on 15 March 2018 and in relation to another horse a tetanus booster, when in fact he had administered the vaccination boosters on 21 March 2018, and that his conduct was misleading, dishonest and undermined the integrity of a vaccination process designed to promote animal welfare.
The third charge was that, on or around 21 March 2018, Dr Jones failed to make any entries in the clinical records for a horse in relation to an examination on 21 March 2018.
At the outset of the hearing Dr Jones admitted the facts in the first and second charges, and accepted that his actions were misleading, dishonest and that they undermined the integrity of a vaccination process. However, he disputed certain aspects of the written statements of the College’s witnesses. In particular he wanted his conduct to be taken in the context of the pressures that he was working under on that day, primarily that he was in a stressed state having had to euthanase a valuable stallion at the conclusion of his previous client appointment.
Dr Jones did not admit the third charge, explaining that he did not remember examining the horse on 21 March 2018 as alleged.
Based on Dr Jones' own admissions, the Committee found the first and second charges proven.
Regarding the third charge, the Committee heard evidence from the horse’s owner who said they were present during the examination taking place and the Committee was satisfied that the respondent did examine the horse on 21 March 2018 and that he had a duty to make a brief clinical note on the examination. As Dr Jones admitted that he made no such note, the Committee found the charge to have been proven to the requisite standard.
Having found the charges proven, the Committee then went on to consider whether or not Dr Jones’ proven conduct amounted to serious professional misconduct. The Committee, having considered the aggravating and mitigating factors, found that Dr Jones’ conduct as found proved in relation to both charges one and two, did constitute serious professional misconduct.
However, with regards to charge three, the Committee accepted that the respondent simply forgot that he had examined the horse and, therefore, the Committee was not satisfied that the failure to compile a record entry covering the horse’s examination constituted serious professional misconduct.
The Committee then considered what sanction to impose on Dr Jones in relation to the facts found proven in charges one and two. In doing so it took into account the 78 written testimonials and 4 character witnesses called on behalf of Dr Jones.
Ian Green, who chaired the Committee and spoke on its behalf, said: "The Committee’s decision on sanction has been based on an acceptance that the respondent’s conduct on this occasion was out-of-character, as the evidence of his character witnesses and the contents of the letters submitted in his support by his clients and other veterinary colleagues assert. The Committee also accepts that the respondent self-reported himself to his employer and to the College and has made a full and frank admission of his wrongdoing.
"Consideration was given to whether the sanction of a reprimand and/or warning as to future conduct would adequately reflect the gravity of the misconduct, however, after careful reflection it was concluded that such a sanction could not be justified. The reason is that acts of falsification involve acts of dishonesty by a professional person acting in a professional capacity, and the gravity of the matter arises not simply from the dishonesty but also from the possible consequences of the false certification. It should be clearly understood by members of the veterinary profession that, in appropriate false certification cases, the sanction of removal from the Register is one which may well be imposed."
The Committee therefore decided that suspending Dr Jones from the Register for two months would be the most appropriate sanction.
Merial is inviting all equine veterinary surgeons that are going to BEVA Congress this year to the launch of updated ProteqFlu, its equine flu vaccine which now includes protection against the latest Clade 2 strains, including Richmond 07.
Speakers at the event include specialist Dr Richard Newton (pictured right), Head of Epidemiology and Disease Surveillance at the Animal Health Trust (AHT), and Dr Romain Paillot Head of Immunology at the AHT. Dr Newton will explain why the inclusion of the Clade 2 strain is so important for horse health, and the equine industry as a whole.
Louise Radford MRCVS from Merial said: "We're all incredibly excited as the event will mark the launch of the UKs first and only fully updated equine flu vaccine that contains both a Clade 1 and Clade 2 antigen. The new ProteqFlu® vaccine fully represents the latest 2014 OIE recommended EIV strains."
The launch is being held at the Hotel Du Vin, Birmingham on Thursday 11 September 2014. Presentations will cover 'A virological and immunological perspective on Clade 2 & EIV', 'How technology makes the difference' and independent vaccine trial results.
The evening starts at 6.30pm and includes dinner and evening entertainment.
To book, contact, Jo Gater-Willats, or Merial Customer Support on 0800 6000123.
The Boehringer Academy (www.boehringer-academy.co.uk) contains hundreds of hours of CPD material on equine, companion and production animals. It comprises a mixture of webinars, podcasts, short videos and downloadable documents, which can be viewed at any time. The site keeps a CPD log for each user and provides downloadable certificates.
Boehringer’s Small Animal Marketing Team Leader, Jemima Mead said: "We already have just over 15,000 vets and nurses in the UK and Ireland currently registered with the Academy.
"New and existing members are eligible to receive the Boehringer Academy colouring book. They simply have to visit www.boehringer-academy.co.uk and complete their profile. In addition, everyone completing their profile will be entered into a draw to win an iPad Pro and Apple Pencil."
The pack contains:
For more information, contact your local Dechra equine sales manager.
Dechra Veterinary Products has launched a new 50 ml bottle of its rapid acting dissociative anaesthetic licensed for cats, dogs and horses, Anesketin.
Anesketin solution for injection, containing Ketamine 100 mg/ml, is indicated for induction of anaesthesia.
Dechra Brand Manager Craig Sankey said: "Anesketin has proved to be a very popular product in our range due to its versatility. It can be used in combination with appropriate sedatives and analgesics in cats, dogs and horses for induction of anaesthesia.
"As it does not require any special temperature storage conditions it makes it a very portable product for vets on the move."
He added: "We are very pleased to be able to add the larger Anesketin product to our wide range of analgesics and sedatives. This demonstrates our commitment to offering high quality products that support vets in small animal and equine practice."
Dechra says the product can also be used as a sole agent for restraint and minor surgical procedures where muscle relaxation is not required in cats.
Anesketin is also available in 10 ml vials. For further information, visit www.dechra.co.uk
The MonitorME project, launched this month, collects antimicrobial usage data from equine practices around the UK, to better understand how antibiotics are used within the sector.
The project is being led by BEVA President Bruce Bladon (pictured) and it will be the main theme at BEVA Congress (10-13 September 2025, ICC Birmingham).
Bruce said: “Growing resistance to antibiotics is a very serious public health crisis, which is why I have chosen it as the overriding theme for my presidential year and for the forthcoming BEVA Congress.
“The World Health Organisation has the usage of veterinary antimicrobials firmly in their sights and the possibility of legislation being implemented to limit our access to these vital drugs is becoming ever more likely.
“It is important that we demonstrate, as a sector, that our usage of antimicrobials is responsible and proportionate, to ensure continued access.
"Taking part in a project like this is, without a doubt, the right thing to do.”
Practices are being asked to submit usage data from their practice management systems (PMS) to the BEVA office, where it will contribute to nationwide reporting of antibiotic use in UK equine practice.
Ideally, they need to record the total mg of each antimicrobial used, together with the number of horses treated last year (in total, not just those treated with antibiotics) and their average weight if available.
The data is analysed and then collated into annual reports, which are published on the BEVA MonitorME webpage.
The 2023 report is now available and will be updated periodically as practices continue to submit their 2023 data.
2024 data collection has started, so equine practices can send their data to antibiotics@beva.org.uk whenever they’re ready.
https://www.beva.org.uk/Resources/Medicines/Antibiotics/MonitorME#aims
https://www.bevacongress.org
Andrea Tarr BPharm MSC MRPharmS, the founder and director of Veterinary Prescriber said: "Prescribing is a neglected aspect of veterinary practice. When it comes to making treatment decisions, vets are very poorly supported by their professional organisations, the pharmaceutical industry has a hugely distorting influence and there's a lack of access to really helpful information.
"We're determined to use the expertise in Veterinary Prescriber to change this, and support vets in their use of medicines in the best interests of animals, their owners and the environment.
"With this in mind, we start the year with a learning module of good veterinary dispensing practice."
The module explains what constitutes a well-run dispensary, including how to organise, handle and store medicines correctly. It reviews the legal classifications of medicines, including controlled drugs and the cascade. It also considers why dispensing errors occur and what to do when they happen.
Veterinary Prescriber says its modules are evidence-based, peer-reviewed and independent of the pharmaceutical industry.
Subscription costs £9.95 per month, which you can cancel any time. To subscribe, visit: www.veterinaryprescriber.org
BEVA has announced that tickets are now on sale for BEVA Congress and members who register before 4th August 2016 can benefit from big discounts.
This year, BEVA Congress is being held at the ICC in central Birmingham.
In addition to the clinical programme, tactics to achieve the elusive work life balance and the applicability of evidence based medicine are recurring themes over the three days of the event.
Five separate programmes will run concurrently in five adjacent halls, deploying a mix of traditional lectures, panel discussions and interactive forums to suit equine vets and mixed practitioners at any stage in their career. Vet nurses, farriers, equine physiotherapists and equine dental technicians can also attend specific sessions focused on their areas of expertise.
There will be daily practical sessions in the exhibition hall: Jonathan Anderson, Will Barker, Tim Barnett, Ollie Crowe, Richard Reardon, Neil Townsend and Thomas Witte will be demonstrating sinoscopy and gastroscopy techniques and delegates will have the chance to roll up their sleeves and get hands on with dead heads and digital models.
Programme highlights include a day of advanced orthopaedics in combination with the European Society of Veterinary Orthopaedics and Traumatology (ESVOT). The sessions will draw on canine and human experience, with speakers including Ian Wright from the Newmarket Equine Hospital, Peter Clegg from the University of Liverpool, Wayne McIlwraith from Colorado State University and Martin Waselau from Equine Hospital Aschheim, Germany.
There will also be career and practice development sessions exploring what you can do with your veterinary degree, how to look after your staff and how to take advantage of smartphone technology in practice. Evidence in surgery and critical appraisal tools will be explored in a series of presentations on two separate days across a wide range of conditions. Speakers will include Will Barker, Bruce McGorum, and Etienne O'Brien.
Kathy Clarke, Professor of Veterinary Anaesthesia at the Royal Veterinary College, will be giving the plenary lecture on from the difficult horse to the demanding surgeon; how effective sedation has revolutionised what is achievable in equine clinical practice. There will be a debate on the Friday with Victoria Harris chairing the promisingly divisive This house believes that lab tests are overused and abused.
There will also be comprehensive sessions on parasitology, laminitis, skin disease, anaesthesia and analgesia, colic, respiratory disease, sports injuries, standing surgery, ophthalmology, diagnostics, wounds, neurology and differentiating lameness from neurological disease, mare and foal, reproduction, dentistry, gastro intestinal disease and nutrition, cardiology and medicine.
Saturday’s vet nurse sessions will cover surgical management, emergency patients, the use of antimicrobials and adjunctive therapies. In addition, daily clinical research presentations will provide exclusive opportunities to hear about novel and exciting research projects.
There's a free BEVA Congress App with the full scientific programme and to help you manage your day. And if you are struggling for time or torn between several lectures you can use the BEVA Congress Encore Room which gives you the chance to play back missed lectures at your convenience.
For more information, visit www.beva.org.uk.
The virtual collection provides a source of evidence to determine what is or is not of clinical significance in cardiac arrhythmia and what might represent the best course of action, if action is needed, within the requisite parameters of safety and welfare.
With an editorial written jointly by Peter Physick-Sheard and Joann Slack the virtual collection includes:
... and more.
Professor Celia Marr, Editor of the EVJ said: “In terms of day-to-day veterinary work, rhythm disturbances are a frequent frustration during prepurchase examinations or perceived poor performance assessments. This outstanding collection brings to hand the most recent evidence to help clinicians support their observations, facilitating diagnosis and a treatment plan in this challenging area.”
The Virtual issue can be downloaded here: https://beva.onlinelibrary.wiley.com/doi/toc/10.1111/(ISSN)2042-3306.irregular-hearts-performance.vi
Vetoquinol has announced the launch of Equistro Flexadin UCII, an equine joint supplement.
Equistro Flexadin UCII contains a new ingredient, UC-II, which the company claims is one of the most effective and influential ingredients available that aids and supports healthy joint function.
To celebrate the launch of Flexadin UCII Vetoquinol is offering a £10 money off voucher available through purchases of Horse & Hound magazine starting from November 10th.
Caitríona Mullin, Equine Product Manager at Vetoquinol UK Ltd said: "We are very excited about the launch of Flexadin UCII in the UK and Ireland, we have already received excellent feedback from our German and French colleagues. Flexadin UCII is a product that will further enhance our premium range of equine supplements formulated specifically for the performance horse."